Elevated Serpine1 expression in CRC correlates with enhanced tumor progression and dissemination, while clinical analyses demonstrate an inverse relationship between SERPINE1 mRNA levels and CD8+ T-cell infiltration, highlighting its potential as a therapeutic target [113]. This evidence concerns the gene CD8A and colorectal carcinoma.